View Older Stories View More Recent Stories
-
BMO Capital Downgrades Dean Foods (DF) to Market Perform
-
Ziopharm Oncology (ZIOP) Prices 10M COmmon Offering at $8.75/Share
-
Walt Disney (DIS) PT Raised to $115 at BMO Capital
-
Notable Analyst Rating Changes 2/3: (NBL) (LNKD) (SYY) Upgraded; (VR) (FCX) (CNP) Downgaded
-
BMO Capital Upgrades Tenet Healthcare (THC) to Outperform
-
BMO Capital Upgrades Blackhawk Network (HAWK) to Outperform
-
Ziopharm Oncology (ZIOP) to Commence $75M Stock Offering
-
ZIOPHARM Oncology Announces Proposed Public Offering of Common Stock
-
Notable Analyst Rating Changes 2/2: (DMND) (CPLP) (DECK) Upgraded; (GES) (GHL) (ARR) Downgraded
-
BMO Capital Upgrades Rock-Tenn (RKT) to Outperform
-
BMO Capital Upgrades MeadWestvaco (MWV) to Outperform
-
BMO Capital Upgrades Diamond Foods (DMND) to Outperform
-
BMO Capital Downgrades ACE Ltd (ACE) to Market Perform
-
BMO Capital Upgrades QLogic (QLGC) to Outperform
-
BMO Capital Upgrades Boston Scientific (BSX) to Outperform
-
BMO Capital Downgrades General Mills (GIS) to Market Perform
-
Post Holdings (POST) 6.5M Offering Prices at $47.50/Share
-
Vitae Pharmaceuticals Announces Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Follow-on Public Offering of Common Stock
-
Auspex Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
ZIOPHARM (ZIOP) Bullish Stance Reiterated at BMO Capital Following Meeting with Dr. at MD Anderson
-
Apple (AAPL) Target Lifted to $130 at BMO Capital Following Q1 Results
-
Apple (AAPL) Earnings on Deck; Blow-Out Expected But FX Could Crimp Margin Expansion
-
Post Holdings (POST) Announces $240M Common Offering
-
Post Holdings Announces Proposed Common Stock Offering
-
Notable Analyst Rating Changes 1/23: (LNKD) (LULU) (CHK) Upgraded; (X) (DWA) (XOM) Downgraded
-
Box, Inc. (BOX) IPO Opens Up 44%
-
Auspex Pharmaceuticals (ASPX) Prices 4M Common Follo-On at $56.50/Share
-
Auspex Announces Pricing of Follow on Offering
-
Vitae Pharmaceuticals (VTAE) Prices 3M Common Follow-On at $11.90/Share
-
Vitae Pharmaceuticals Announces Pricing of Follow-on Public Offering of Common Stock
-
BMO Capital Downgrades Altera (ALTR) to Market Perform
-
Box, Inc. (BOX) Prices 12.5M Common IPO Above Previously Expected Range at $14/Share
-
BMO Capital Starts ServiceNow (NOW) at Outperform
-
Notable Analyst Rating Changes 1/22: (CHUY) (ALU) (AMCX) Upgraded; (EMR) (AZPN) (ADVS) Downgraded
-
BMO Capital Downgrades Packaging Corp. of America (PKG) to Market Perform
-
BMO Capital Starts Synaptics (SYNA) at Outperform
-
Physicians Realty Trust (DOC) Closes Larger 18.98M Common Offering
-
BMO Capital Upgrades Joy Global (JOY) to Outperform
-
BMO Capital Downgrades Navistar International (NAV) to Underperform
-
BMO Capital Downgrades PACCAR (PCAR) to Underperform
-
Auspex Pharmaceuticals (ASPX) Announces 4M Common Offering
-
Auspex Announces Proposed Public Offering of Common Stock
-
ZIOPHARM (ZIOP) Bullish Stance Reiterated at BMO Capital Following MSKCC Pre-Clinical CAR-T Data
-
Intercept Pharmaceuticals (ICPT) Bullish Stance Reiterated at BMO Capital amid American Journal of Pathology OCA Data
-
Notable Analyst Rating Changes 1/20: (BAC) (MU) (EXC) Upgraded; (ADM) (INTC) (YNDX) Downgraded
-
Notable Mergers and Acquisitions 1/20: (EXPR) (BABA) (GG) (RLGT)
-
Goldcorp (GG) to Acquire Probe Mines in C$526M Deal
-
Vitae Pharmaceuticals Launches Proposed Follow-on Public Offering of Common Stock
-
BMO Capital Starts Lending Club (LC) at Outperform
-
Patriot National (PN) IPO Opens for Lower


